REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Swixx Biopharma d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Swixx Biopharma d.o.o. is an enterprise based in Croatia. Its main office is in Zagreb. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on January 13, 2026. It currently has a total number of 67 (2024) employees. From the latest financial highlights, Swixx Biopharma d.o.o. reported a net sales revenue increase of 39.41% in 2024. There was a total growth of 167.94% in Swixx Biopharma d.o.o.’s total assets over the same period. The net profit margin of Swixx Biopharma d.o.o. decreased by 0.53% in 2024.

Headquarters
Damira Tomljanovica - Gavrana 15 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Swixx Biopharma d.o.o. report to view the information.

Website: http://www.swixxbiopharma.com

Basic Information
Total Employees:
Purchase the Swixx Biopharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma d.o.o. report to view the information.
Incorporation Date:
January 13, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
39.41%
Total operating revenue
39.41%
Operating profit (EBIT)
7.65%
EBITDA
6.84%
Net Profit (Loss) for the Period
11.1%
Total Assets
167.94%
Total Equity
37.09%
Operating Profit Margin (ROS)
-0.84%
Net Profit Margin
-0.53%
Return on Equity (ROE)
-6.33%
Quick Ratio
-0.14%
Cash Ratio
-0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?